Found 252 clinical trials
Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
The most severe manifestations of COVID-19 include respiratory failure, coagulation problems, and death. Inflammation and blood clotting are believed to play an important role in these manifestations. Research in humans has shown that dipyridamole can reduce blood clotting.
clot
covid-19
acute respiratory syndrome (sars)
blood clotting
hypercoagulable state
- 0 views
- 05 Aug, 2020
COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO)
Objective To learn more about how SARS-CoV-2 affects lymphocytes, the immune, and the blood clotting system. Eligibility Adults age 18 and older who either currently have COVID-19 or have recently recovered from it Design Participants will give a blood sample.
- 0 views
- 16 Feb, 2024
- 3 locations